Biocryst医药(BCRX)

丰硕创投04-19 16:20

$Biocryst医药(BCRX)$ 2024年1月5日，BioCryst公司宣布用于治疗HAE的血浆激肽释放酶抑制剂ORLADEYO®(berotralstat)的2023年初步销售额为3.25亿美元，符合23Q3时给出的销售指引，并给出2024年销售指引为3.8-4亿美元。查看全文

持股变动声明

Biocryst医药(BCRX)05-15 19:15

$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-015367  Size: 4 KB 网页链接查看全文

季度财报

Biocryst医药(BCRX)05-08 04:15

$Biocryst医药(BCRX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-24-021069  Act: 34  Size: 7 MB 网页链接查看全文

持股变动声明

Biocryst医药(BCRX)05-22 19:35

$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-016190  Size: 4 KB 网页链接查看全文

持股变动声明

Biocryst医药(BCRX)06-15 04:35

$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018737  Size: 6 KB 网页链接查看全文

股东委托书协议

Biocryst医药(BCRX)04-26 04:25

$Biocryst医药(BCRX)$ DEF 14A Other definitive proxy statements Accession Number: 0001628280-24-018175  Act: 34  Size: 3 MB 网页链接查看全文

其他

Biocryst医药(BCRX)04-26 04:35

$Biocryst医药(BCRX)$ ARS Annual Report to Security Holders Accession Number: 0001140361-24-022074  Act: 34  Size: 1 MB 网页链接查看全文

持股变动声明

Biocryst医药(BCRX)05-15 19:15

$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-015363  Size: 4 KB 网页链接查看全文

持股变动声明

Biocryst医药(BCRX)05-15 19:25

$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-015369  Size: 4 KB 网页链接查看全文

持股变动声明

Biocryst医药(BCRX)06-15 04:25

$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018711  Size: 8 KB 网页链接查看全文

薛定锷之猫2018-03-23 01:47

$Biocryst医药(BCRX)$ 与IDRA合并，取消关注查看全文

薛定锷之猫2018-02-21 04:04

$Biocryst医药(BCRX)$ 管理层跟股东打架：管理层想跟IDRA合并，GREATPOINT因为觉得BCX-7353低估要阻拦查看全文

Dianxie2018-01-04 00:42

$Biocryst医药(BCRX)$ 5块5查看全文

LBQUS2018-01-02 22:48

$Biocryst医药(BCRX)$ 出利好了：BioCryst Pharmaceuticals (NASDAQ:BCRX) upgraded to Outperform by RBC Capital Markets. Shares up 3% premarket on light volume.查看全文

美股马甲2017-10-14 06:48

$Biocryst医药(BCRX)$ 这个关注这么少？ 查看全文

6666六六2017-09-12 16:37

$Biocryst医药(BCRX)$ 这个股票会到12-15的 立贴为证查看全文

kwansyu2-c2017-08-12 09:14

$Biocryst医药(BCRX)$ 打仗需要生物股查看全文

kwansyu2-c2017-06-20 23:48

$Biocryst医药(BCRX)$ YoYo. 當大家當我傻 B，我又在撿錢了。明天餐早茶有著落查看全文

kwansyu2-c2017-05-16 20:37

$Biocryst医药(BCRX)$先買回一點，最近跌很多，我依然看好出血性病毒疫苗的潛力查看全文

交易者的天空2017-03-03 11:26

3-3 WatchlistP2
$英伟达(NVDA)$ $Biocryst医药(BCRX)$ $易车(BITA)$
Youtube:网页链接
单讲一下Day trading broker 与 retail broker的区别
网页链接查看全文

美股异动 | WSB散户宣布“生物科技战”，遭沽空医药股盘前普涨，BioCryst制药(BCRX.US)涨超10%

智通财经APP获悉，2月2日（周二）美股盘前，WSB散户宣布“生物科技战”，受散户追捧的生物技术股票普涨。截至发稿，BioCryst制药(BCRX.US)涨10.57%，诺瓦瓦克斯医药 (NVAX.US)涨4.36%、德纳维制药(DVAX.US)涨10.03%、Inovio Pharmaceuti... 网页链接

Reddit大军向空头宣布“生物科技战” 若干被沽空生物科技股大涨

Reddit大军向空头宣布“生物科技战”，若干被沽空生物科技股大幅上涨。Biocryst医药（BCRX）股价上涨逾40%，刷新2015年10月份以来盘中高位至11.98美元。 Reddit的WallStreetBets论坛上，有用户称该制药公司是“市场上被低... 网页链接

持股变动声明

$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018715  Size: 9 KB 网页链接

持股变动声明

$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018720  Size: 6 KB 网页链接

持股变动声明

$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018725  Size: 6 KB 网页链接

持股变动声明

$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018728  Size: 6 KB 网页链接

持股变动声明

$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018733  Size: 6 KB 网页链接

持股变动声明

$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018737  Size: 6 KB 网页链接

持股变动声明

$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018705  Size: 6 KB 网页链接

持股变动声明

$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018708  Size: 7 KB 网页链接

持股变动声明

$Biocryst医药(BCRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-24-018711  Size: 8 KB 网页链接

证券出售报告

$Biocryst医药(BCRX)$ 144 Report of proposed sale of securities Accession Number: 0001971857-24-000403  Act: 33  Size: 4 KB 网页链接